Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep Redon

Showing results (151-160 of 271) with videos related to

Pageof 28
Sort By:
Journal of Nephrology|August 18, 2020
Urinary exosomal miR-146a as a marker of albuminuria, activity changes and disease flares in lupus nephritisJavier Perez-Hernandez, Olga Martinez-Arroyo, Ana Ortega, et al.
Hypertension (Dallas, Tex. : 1979)|March 16, 2016
An Expert Opinion From the European Society of Hypertension-European Union Geriatric Medicine Society Working Group on the Management of Hypertension in Very Old, Frail SubjectsAthanase Benetos, Christopher J Bulpitt, Mirko Petrovic, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 5, 2013
Updated ESH position paper on interventional therapy of resistant hypertensionRoland E Schmieder, Josep Redon, Guido Grassi, et al.
Journal of Hypertension|April 4, 2012
ESH position paper: renal denervation - an interventional therapy of resistant hypertensionRoland E Schmieder, Josep Redon, Guido Grassi, et al.
Frontiers in Cardiovascular Medicine|February 7, 2022
Real-World Data of Anticoagulant Treatment in Non-valvular Atrial FibrillationJose Miguel Calderon, Fernando Martinez, Javier Diaz, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 28, 2026
Revealing Sex Differences in Hypertensive Urgency Management: Insights From a Tertiary HospitalGrethzel Prado, Carlos Bea, Elena Martínez, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 24, 2025
Usefulness of Arterial Stiffness as an Integrated Marker of Cardiovascular RiskGrethzel Prado, María J Forner, Oscar Calaforra, et al.
Circulation|September 28, 2011
Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)Giuseppe Mancia, Helmut Schumacher, Josep Redon, et al.
Journal of Hypertension|September 5, 2020
Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trialsGiuseppe Mancia, Helmut Schumacher, Michael Böhm, et al.
American Journal of Hypertension|January 3, 2007
Inadequate cytoplasmic antioxidant enzymes response contributes to the oxidative stress in human hypertensionFelipe J Chaves, Maria L Mansego, Sebastian Blesa, et al.
Pageof 28

Showing results (151-160 of 271) with videos related to

Sort By:
Pageof 28
Journal of Nephrology|August 18, 2020
Urinary exosomal miR-146a as a marker of albuminuria, activity changes and disease flares in lupus nephritisJavier Perez-Hernandez, Olga Martinez-Arroyo, Ana Ortega, et al.
Hypertension (Dallas, Tex. : 1979)|March 16, 2016
An Expert Opinion From the European Society of Hypertension-European Union Geriatric Medicine Society Working Group on the Management of Hypertension in Very Old, Frail SubjectsAthanase Benetos, Christopher J Bulpitt, Mirko Petrovic, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 5, 2013
Updated ESH position paper on interventional therapy of resistant hypertensionRoland E Schmieder, Josep Redon, Guido Grassi, et al.
Journal of Hypertension|April 4, 2012
ESH position paper: renal denervation - an interventional therapy of resistant hypertensionRoland E Schmieder, Josep Redon, Guido Grassi, et al.
Frontiers in Cardiovascular Medicine|February 7, 2022
Real-World Data of Anticoagulant Treatment in Non-valvular Atrial FibrillationJose Miguel Calderon, Fernando Martinez, Javier Diaz, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 28, 2026
Revealing Sex Differences in Hypertensive Urgency Management: Insights From a Tertiary HospitalGrethzel Prado, Carlos Bea, Elena Martínez, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 24, 2025
Usefulness of Arterial Stiffness as an Integrated Marker of Cardiovascular RiskGrethzel Prado, María J Forner, Oscar Calaforra, et al.
Circulation|September 28, 2011
Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)Giuseppe Mancia, Helmut Schumacher, Josep Redon, et al.
Journal of Hypertension|September 5, 2020
Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trialsGiuseppe Mancia, Helmut Schumacher, Michael Böhm, et al.
American Journal of Hypertension|January 3, 2007
Inadequate cytoplasmic antioxidant enzymes response contributes to the oxidative stress in human hypertensionFelipe J Chaves, Maria L Mansego, Sebastian Blesa, et al.
Pageof 28